SO WHAT: If you purchased ICON ordinary shares during the Class Period you may be entitled to compensation without payment of ...

If you suffered losses exceeding $75,000 in ICON between July 27, 2023 and October 23, 2024 and would like to discuss your ...

BofA said equity investors rotated into bond-sensitive sectors, such as pharma, biotech, utilities and REITs, and to Europe, as a measure of investor fear of a global recession fell to a 3-year low ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

Glancy Prongay & Murray LLP reminds investors of the upcoming April 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise ...

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

ICON Plc 's stock (NASDAQ:ICLR) has reached a 52-week low, dipping to $183.31, as the company navigates through a turbulent market environment. With a market capitalization of $15.19 billion and a P/E ...

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) ordinary shares between ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology ...

Stepping into the CCO role, Colin Stanley brings over 25 years of sector experience and a proven track record in business ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...